Difference between revisions of "CD91-105"
From Opengenome.net
| Line 62: | Line 62: | ||
<tr> | <tr> | ||
<td><strong> CD97</strong></td> | <td><strong> CD97</strong></td> | ||
| − | <td> </td> | + | <td> 75-85</td> |
| − | <td> </td> | + | <td> BL-KDD/F12 </td> |
| − | <td> </td> | + | <td> Activated B and T cells, monocytes, granulocytes</td> |
| − | <td> </td> | + | <td> Binding to CD55</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD98</strong></td> | <td bgcolor="#cccccc"><strong> CD98</strong></td> | ||
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 125</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 4F2, FRP-1, RL-388 in mouse </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Not hemaopoeitic specific; activated and transformed cells; lower levels on quiescent cells </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Role in regulation of cellular activation </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD99</strong></td> | <td><strong> CD99</strong></td> | ||
| − | <td> </td> | + | <td> 32</td> |
| − | <td> </td> | + | <td> CD99R (epitope restricted to subset of CD99 molecules), E2, MIC2 gene product </td> |
| − | <td> </td> | + | <td> Peripheral-blood lymphocytes, thymocytes </td> |
| − | <td> </td> | + | <td> Not known </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD100</strong></td> | <td bgcolor="#cccccc"><strong> CD100</strong></td> | ||
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 300, 120</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Most </td> |
<td bgcolor="#cccccc"> </td> | <td bgcolor="#cccccc"> </td> | ||
</tr> | </tr> | ||
Revision as of 15:26, 8 September 2006
|
CD antigen |
MW.(kDa) |
Synonyms & Properties |
Leukocyte expression |
Function |
| CD91 | 515, 85 | α-2 macroglobulin receptor (ALPHA2M-R), low density lipoprotein-receptor-related protein (LRP) | Monocytes, many non-hematopoeitic cells | 2-macroglobulin receptor |
| CDw92 | 70 | GR9 | Monocytes, granulocytes, peripheral blood lymphocytes (PBL) | Not known |
| CDw93 | 110 | GR11 | Monocytes, granulocytes, endothelial cells | Not known |
| CD94 | 70 | Kp43; forms complex with NKG2-A (which contains cytoplasmic immunoreceptor tyrosine-based inhibition motifs) | NK cells, subsets of CD8+ αβ and γδ T cells | Subunit of complex with NKG2-A that is involved in inhibition of NK cells |
| CD95 | 45, 90, >/200 | APO-1, Fas antigen (Fas) | Activated T and B cells | Mediation of apoptosis-inducing signals |
| CD96 | 160 | T-cell activation increased late expression (TACTILE) | Activated T cells, NK cells | Not known |
| CD97 | 75-85 | BL-KDD/F12 | Activated B and T cells, monocytes, granulocytes | Binding to CD55 |
| CD98 | 125 | 4F2, FRP-1, RL-388 in mouse | Not hemaopoeitic specific; activated and transformed cells; lower levels on quiescent cells | Role in regulation of cellular activation |
| CD99 | 32 | CD99R (epitope restricted to subset of CD99 molecules), E2, MIC2 gene product | Peripheral-blood lymphocytes, thymocytes | Not known |
| CD100 | 300, 120 | Most | ||
| CD101 | ||||
| CD102 | ||||
| CD103 | ||||
| CD104 | ||||
| CD105 |
